• NRx and Israel partner to advance Covid-19 vaccine development pharmaceutical-technology
    July 13, 2021
    NRx Pharmaceuticals has entered a memorandum of understanding with the Government of Israel to licence exclusive global development, manufacturing and commercialisation rights to a Covid-19 vaccine, BriLife.
PharmaSources Customer Service